The present application is a continuation of U.S. patent application Ser. No. 11/529,614, filed Sep. 29, 2006, which issued as a U.S. Pat. No. 9,380,974 on Jul. 5, 2016, which claims priority pursuant to 35 U.S.C. § 119(e) to U.S. Patent Application Ser. No. 60/721,966, filed Sep. 30, 2005, the entire content of each of which is incorporated herein by reference.
The present invention relates to devices, arrangements and methods for facilitating the sampling, collection and analysis of body fluids. In certain embodiments, the present invention can be directed to a cartridge that can be utilized in conjunction with an integrated body fluid sampling and monitoring devices.
In the discussion that follows, reference is made to certain structures and/or methods. However, the following references should not be construed as an admission that these structures and/or methods constitute prior art. Applicants expressly reserve the right to demonstrate that such structures and/or methods do not qualify as prior art.
According to the American Diabetes Association, diabetes is the fifth-deadliest disease in the United States and kills more than 213,000 people a year, the total economic cost of diabetes in 2002 was estimated at over $132 billion dollars. One out of every 10 health care dollars is spent on diabetes and its complications. The risk of developing type 1 juvenile diabetes is higher than virtually all other chronic childhood diseases. Since 1987 the death rate due to diabetes has increased by 45 percent, while the death rates due to heart disease, stroke, and cancer have declined.
A critical component in managing diabetes is frequent blood glucose monitoring. Currently, a number of systems exist for self-monitoring by the patient. Most fluid analysis systems, such as systems for analyzing a sample of blood for glucose content, comprise multiple separate components such as separate lancing, transport, and quantification portions. These systems are bulky, complicated and confusing for the user. The systems require significant user intervention to perform repeated testing.
Some attempts have been made to integrate some or all of these functions. For instance, a device has been developed that contains a disposable array of test strips. This device integrates the functions of transport and quantification only. Another device attempts to integrate all three of the above-mentioned functions. However this device is single use, and the user must reload a test strip and lancet for each test. The device is also very large and requires significant user intervention. For instance, this device has separate members to create and to transport a sample. The wound is created with a lancet and a test strip collects a sample. This system uses several complicated mechanisms to bring the test strip to a position where it can collect the sample. Finally, the device is not configured for fingertip testing.
Another device contains an array of quantification strips and dispenses one strip at a time, without the function of automated lancing or sample transport.
Yet another device includes a disposable insert that may contain an array of lancets and possibly test strips. Yet the device is large, cumbersome, and non-wearable. The device may be expensive.
In addition, in those devices where such integration has been attempted, the mechanism(s) for actuating the skin-piercing members are provided in the reusable portion of the device and not in the cartridge. These actuation mechanisms are overly complex and bulky so that their inclusion into a disposable cartridge has been impractical.
In summary, most current systems that are not integrated involve many pieces that are not convenient and make the test difficult to perform discreetly. Other current devices may be somewhat integrated but still require significant user intervention, are not discreet, are overly complex and bulky and require more than one device to complete the test.
According to the present invention, there are provided body fluid sampling and monitoring devices and methods that may address one or more of the shortcomings noted above associated with conventional arrangements and devices.
Although not required, the present invention can provide devices, arrangements and techniques which possess one or more of the following advantages:
Convenience and Simplicity—according to the principles of the present invention the user can carry a single disposable cartridge which is capable of completing multiple tests.
Reduced Risk of Infection and Cross-Contamination—a cartridge formed according to the present invention ensures that the user can access a fresh lancet and test strip for every testing event, and that contaminated articles are contained and stored within the cartridge which acts like a self-contained receptacle.
Reduced Environmental Contamination of the Reagent—conventional systems protect test strips from environmental contamination by storing them in a plastic vial or other container. As soon as this container is opened, all the strips are exposed to the environment. This exposure can result in deterioration of the reagent contained in the test strips. According to the present invention, each reagent-containing test strip can be shielded from the environment in a chambers formed within the cartridge.
Improved Reliability—rather than relying on intervention by the user to deliver a sample to an analysis site (e.g., test strip), the present invention can automatically transfer a sample body fluid to an analysis site.
Automatic Calibration and Accuracy Verification—conventional systems typically require the user to input a calibration code for each new series of test strips. This procedure can be confusing and is often performed incorrectly, or ignored by the user. According to the present invention, calibration information will be provided on each cartridge and automatically read by an integrated meter or device upon insertion of the cartridge therein. Similarly, each cartridge can comprise one or more analysis sites which act as a control. For example, upon reading and analyzing the control representing a known concentration of analyte, the results obtained by the integrated meter are then compared to this known concentration. Any deviation therefrom can be accounted for and corrected by, for example, updating or modifying the algorithm utilized to calculate the concentration of analyte contained in the sample body fluid.
Automatic Algorithm and Software Update Capabilities—the cartridge of the present invention may include the readable information (e.g., in the form of a chip) which can be utilized to automatically update the software, firmware, algorithm and/or analysis method of the integrated meter or device upon insertion of the cartridge therein.
As used herein “digital” or “digit” means fingers or toes. “Digital body fluid” means expression of body fluid from a wound created on the fingers or toes, and encompasses lancing sites on the dorsal or palm side of the distal finger tips.
As used herein “alternate-site” means a location on the body other than the digits, for example, the palm, forearm or thigh. “Alternate-site body fluid sampling” means expression of body fluid from the lancing site on a surface of the body other than the fingers or toes, and encompasses lancing sites on the palm, forearm, and thigh.
As used herein, “body fluid” encompasses whole blood, intestinal fluid, and mixtures thereof.
As used herein “integrated device” or “integrated meter” means a device or meter that includes all components necessary to perform sampling of body fluid, transport of body fluid, quantification of an analyte, and display of the amount of analyte contained in the sample of body fluid.
According to one aspect, the present invention is directed to an arrangement comprising: a housing; a plurality of sampling and analysis sites contained within the housing, each of the sampling and analysis sites comprising: a skin-penetration member having a first end configured to pierce the skin, and a inner lumen in communication with the first end; an actuator operatively associated with the skin-penetration member; and an analyte quantification member in fluid communication with the inner lumen of the skin-penetration member.
According to another aspect, the present invention is directed to an integrated meter or device comprising the above-identifed arrangement.
The following description of preferred embodiments can be read in connection with the accompanying drawings in which like numerals designate like elements and in which:
According to a first aspect of the present invention, there are provided arrangements and techniques for sampling and analyzing body fluid to determine a concentration of a target analyte contained therein. Target analytes include, but are not limited to, glucose, bilirubin, alcohol, controlled substances, toxins, hormones, proteins, etc. The arrangements and techniques are suitable for use in sampling body fluid from a digit or from an alternate site.
Generally, the arrangement of the present invention may comprise a disposable arrangement. The disposable arrangement may be in the form of a cartridge. The present invention may also comprise an integrated meter comprising a disposable arrangement (e.g., cartridge) as well as a reusable portion. The cartridge may include an array of skin piercing elements attached to guides, triggers and/or actuation mechanisms. The cartridge may also include mechanisms for transporting a sample of body fluid from the skin surface into other areas of the device. According to certain embodiments, at least a portion of the transport operation is integrated into the skin-piercing elements. The cartridge may also include analyte quantification members that may be separate from or integrated with the transport member. The analyte quantification members may be designed to optically or electrochemically indicate detectable changes when exposed to the analyte of interest. The cartridge may also include one or more skin-interfacing members, possibly a soft silicone footprint. The skin interfacing member(s) or footprint(s) can optionally be constructed of any material that facilitates sample acquisition via conditioning the skin prior to, during and/or after piercing. Alternatively, the skin interface member(s) may be included in the reusable portion of the device. The disposable portion may include an energy source. The disposable portion may also include a housing designed to enclose, and/or seal the analyte medium. The disposable portion may also include mechanisms, or be designed to allow for user-adjustable skin piercing depth. The disposable portion may also include vacuum chambers as well as a means to provide an airtight seal against the skin. Finally, the disposable portion may contain readable information usable for calibration, control or software updating purposes.
An arrangement formed according to one exemplary embodiment of the present invention is illustrated in
The housing 12 can be provided in any suitable form. One optional configuration is illustrated in
According to the illustrated embodiment, the housing 12 further comprises a transparent optical window 18. The transparent optical window 18 can be provided, for example, in order to permit optical communication between a detection device and one or more components located within the arrangement or cartridge 10.
The housing 12 can further include a top cover 20. An inner frame 22 can also be provided. The inner frame 22 may help define a plurality of analysis sites 24 within the cartridge 10.
One beneficial aspect of the arrangement or cartridge 10 of the present invention is that it may be used to carry information which is readable by the device into which it is inserted. Such information can be used to update data and/or code utilized by the device, and can also be used for purposes of accuracy verification and calibration. Various mechanisms can be associated with the cartridge tend to accomplish this purpose, as will be evident to those of ordinary skill in the art. Two exemplary mechanisms are illustrated in
Another beneficial aspect of the arrangement described above is the ability to utilize one or more of the analysis sites 24 for calibration and control purposes. Generally, one or more of the analysis sites 24 can be used to verify the accuracy of test readings and automatically calibrate the system to compensate for any variations which may occur with operation of the device. One such technique and arrangement is illustrated in
As an alternative to the above control assay pad 30′, a control fluid can be released into an assay pad and allowed to react with a chemical reagent contained therein. Since the control fluid contains a known concentration of analyte, the measured concentration of analyte can then be compared to the known concentration, and any differences analyzed and compensated for in the manner described above.
Each sampling and analysis site 24 of the illustrated embodiment comprises a skin penetration member 26. Each skin penetration member 26 can take any suitable form. According to the illustrated embodiment, each skin penetration member 26 is in the form of a hollow needle and has a first in the portion 26e configured to pierce the skin, as well as an inner lumen 26l (
The least one skin-penetration member can be formed of any suitable material, such as metal, plastic, glass, etc.
Each skin-penetration member can be attached to a hub 32. Each hub 32 is, in turn, attached to an actuator 28. It should be understood that a number of different actuators may be utilized according to the principles of the present invention. The actuators can be mechanical, electrical, pneumatic, etc. According to the illustrated embodiment, the actuator 28 is in the form of a torsional spring. Upon activation, the torsional spring drives the hub 32 and the attached skin penetration member 26 through a respective aperture 16 and into the skin of the user. According to certain embodiments, each sampling and analysis site 24 further comprises and analyte quantification member which produces a detectable signal when contacted with a target analyte contained in a sample of body fluid. A number of suitable members are envisioned. The members may be based on conventional technologies such as photometric or electrochemical analysis. According to the illustrated embodiment, an assay pad 30 is provided on each hub 32 which can generally comprises an absorbent material containing a chemical reagent which, upon reaction with a target analyte, produces a chemical reaction that results in a detectable signal. The assay pad 30 is in fluid communication with the inner lumen 22e of the skin piercing element 22. As noted above, the signal can be detected optically, electrochemically, or by other suitable means. According to one embodiment, the assay pad 30, upon reaction with the target analyte, produces a spot which is optically detected by any suitable arrangement or technique. As schematically illustrated, for example, in
Various mechanisms for triggering actuation of a hub 32 and attached skin penetration member 26 will now be described.
In the exemplary, nonlimiting arrangement illustrated in
A similar configuration is illustrated in
A further variation of the above arrangements is depicted in
Further alternative embodiments of a triggering mechanism formed according to the principles of present invention are illustrated in
A further modification of the arrangement of
A further embodiment of the triggering mechanism formed according to the present invention is illustrated in
A triggering mechanism constructed to still another embodiment of the present invention is illustrated in
As illustrated in
A further alternative triggering or release mechanism and arrangement formed according to the present invention is illustrated in
When the hub 32 is positioned in the chamber 81 in a locked position, the rear leg 36 and the forward leg 38 are biased away from one another, such that upon disengagement of the locking features 86, 88, (
A further optional triggering mechanism constructed according to the principles of the present invention is illustrated in
The arrangement 10 can form at least part of a device which functions only to sample body fluid. For example, the arrangement 10 can be used to express body fluid in the form of a drop of blood which pools on the surface of the skin of the user. This drop of blood can then be transferred to another separate device which then transports and/or analyzes the sample for a target analyte. Alternatively, the arrangement 10 may express a sample of body fluid from the digit D, and then transport the sample to a location which can then be accessed for further analysis by a separate device. For instance, the sample body fluid can be transported to a reagent-containing pad, also contained within the arrangement 10. The sample then reacts with the reagent to produce a detectable spot or signal. The reagent pad can then be analyzed by a separate meter using photochemical, electrochemical, or other suitable techniques known per se to those skilled in the art. The reagent pad can remain within the arrangement 10 during the aforementioned analysis. Alternatively, the reagent pad can be removed from the arrangement 10 and inserted into a separate device, such as an electrochemical or photometric meter.
According to a further aspect of the present invention, the above-described arrangements and techniques as previously described herein, can form at least part of an integrated device. As previously noted, as used herein, the term “integrated device” or “integrated meter” means a device or meter that includes all components necessary to perform sampling of the body fluid, transport of the body fluid, quantification of an analyte, and display of the amount of analyte contained in the sample body fluid. Thus, according to the principles of the present invention, an integrated device or meter can comprise one or more, or any combination, of the features previously described herein. According to further aspects of the present invention, and integrated meter or device can comprise additional components and/or features, which are described as follows.
It should be understood that while not required, any of the above-described triggering mechanisms can form part of a separate sampling only device or part of an integrated device into which the cartridge 10 is placed.
One such integrated meter is illustrated
In this regard, light emitted from the light source 124 is incident upon an assay pad (e.g., 30), and reflects off the surface thereof. Upon formation of a reaction spot on the surface of the assay pad, the amount of light reflected off the reaction spot differs from the light reflected off of other portions of the reagent pad containing no such reaction spot. This reflected light is picked up by the detector 126. The detector 126 may comprise a lens 128 and optical detector element 130.
The optical detector element 130 generally comprises one or more detector elements. According to one alternative construction, the detector element 130 comprises a plurality of detector elements formed in an array. The array can take any suitable configuration, and can be a linear array according to one nonlimiting example. The detector elements can comprise any suitable construction. For example, the detector elements 130 can comprise a photo diode, CCD, or CMOS based detector element. The signals transmitted to the detector element 130 are passed on to suitable electronics contained within the housing 112 via suitable electrical connectors, such as flexible ribbons 131 (
An integrated meter incorporating an arrangement formed according to the present invention can be configured for digital body fluid sampling and analysis as well as alternate-site body fluid sampling and analysis, which may be performed at either location at the election of the user.
As evident from
As previously noted, according to certain embodiments of the present invention, the concentration of an analyte contained in a sample of body fluid can be measured using a photometric technique wherein the assay pad is interrogated with a light source and a detector thereby producing a signal indicative of a color change caused by reaction between an analyte and reagent contained in the assay pad, which is then correlated to the concentration of analyte contained in the sample.
The present invention provides photometric analysis devices, arrangements and techniques that facilitate their incorporation into devices and arrangements of the type described above that are compact, discrete, wearable or handheld, and capable of performing multiple tests without reloading testing components.
According to a first embodiment, a photometric analysis arrangement constructed to satisfy at least the above-noted objectives is illustrated in
According to the arrangement 300, the plurality of assay pads 304 are provided at fixed locations relative to the platform or stage 302. Thus, no relative movement between the assay pads 304 and the platform 302 is possible. The light source 306 and the detector 308 are also provided at fixed locations independent of the platform or stage 302. The light source 306 is arranged to direct light toward a specific assay pad 304 when brought into registry therewith. Similarly, the detector 308 is arranged to receive light reflected off the assay pad that is positioned at a predetermined location. The platform 302 is rotatable, as indicated by the arrow contained in
A variation of the arrangement 300 is depicted in
A further optional modification of the arrangements 300,400 is depicted in
In certain instances, it may be advantageous to eliminate the need to move the assay pads 304 relative to the light source 306 and the detector 308 in order to selectively index or bring the components into registry therewith for analysis. Once such arrangement which accomplishes this objective is illustrated in
One possible variation of the arrangement 110 is depicted in
An exemplary body fluid sampling and analysis methodology or technique, which may be utilized in conjunction with any of the above-mentioned arrangements, devices or integrated meters, but is not necessarily limited thereto, is described as follows.
A user loads a fresh disposable cartridge containing a plurality of skin penetration members and analysis sites into an integrated meter. The integrated meter then reads calibration data contained in or on the cartridge. This data can be read in any suitable manner. For example, a bar code may be placed on the cartridge which can be optically read by the optical assembly contained within the meter. Alternatively, the data is contained on a chip carried by the cartridge that is read upon insertion into the integrated meter. The integrated meter then selects the proper lookup table or algorithm to calculate an aggregate glucose measurement taking into consideration the calibration data. The meter may then place itself in a ready mode waiting for a trigger to initiate sampling and testing. The user then either manually presses a button or trigger to initiate sampling and analysis, or the device verifies that it is properly positioned on the skin of the user and ready to begin the sampling and analysis procedure. Suitable sensors to accomplish this include optical, capacitive or pressure sensors. The device may then initiate a catalyst which acts to facilitate the expression of body fluid. According to one alternative embodiment, the catalyst is an inflatable member that exerts pressure on a digit. Alternatively, the catalyst is vacuum pressure which generates suction at the sampling site. Sensors present in the meter may be used to monitor and control the positive or negative pressure of the catalyst. After achieving a target pressure for a desired period of time, the skin penetration member (e.g., a hollow needle) is actuated and driven into the skin of the user to create a wound site. The skin penetration member comes to rest in or directly on the wound created at the sampling site where it is in the desired position for collecting a sample of body fluid expressed from the wound. The integrated meter may further include a mechanism for detecting a whether a sufficient amount of sample has been expressed. Details of such suitable detection techniques are described in detail in U.S. Pat. No. 7,052,652, entitled ANALYTE CONCENTRATION DETECTION DEVICES AND METHODS, the entire content of which is incorporated herein by reference. Once the desired amount of body fluid has been obtained, the catalyst is deactivated. A sample of body fluid is in fluid communication with a device or mechanism which creates a detectable signal upon reaction within analyte present in the sample body fluid. For example, one such suitable mechanism is an absorbent pad containing a chemical reagent which, upon reaction with the analyte produces a reaction spot which can be optically detected. An optical assembly which is an optical communication with the above described signal generating mechanism is utilized to detect the signal created via reaction with the analyte and communicate the signals to supporting electronics contained within the meter. The concentration of a target analyte (e.g., glucose) can then be calculated using these signals as a basis. Additional factors may be considered during these calculations, such as the sample size, levels of other substances contained in the sample (e.g. hematocrit), etc. Such optional calculation techniques are described in further detail in U.S. patent application Ser. No. 11/239,122, entitled ANALYTE DETECTION DEVICES AND METHODS WITH HEMATOCRIT/VOLUME CORRECTION AND FEEDBACK CONTROL, the entire content of which is incorporated herein by reference. These calculations quantify the amount of analyte contained in the sample body fluid. This quantity is displayed on a suitable display contained within the meter which can be easily read by the user. The integrated meter then automatically indexes the disposable cartridge to present a fresh unused skin penetration member which will be utilized to perform the next sampling and analysis event.
Numbers expressing quantities of ingredients, constituents, reaction conditions, and so forth used in this specification are to be understood as being modified in all instances by the term “about”. Notwithstanding that the numerical ranges and parameters setting forth, the broad scope of the subject matter presented herein are approximations, the numerical values set forth are indicated as precisely as possible. Any numerical value, however, inherently contains certain errors necessarily resulting from the standard deviation found in their respective measurement techniques. None of the elements recited in the appended claims should be interpreted as invoking 35 U.S.C. § 112, ¶6, unless the term “means” is explicitly used.
Although the present invention has been described in connection with preferred embodiments thereof, it will be appreciated by those skilled in the art that additions, deletions, modifications, and substitutions not specifically described may be made without department from the spirit and scope of the invention as defined in the appended claims.
Number | Name | Date | Kind |
---|---|---|---|
842690 | Oswalt | Jan 1907 | A |
D137874 | Partridge | May 1944 | S |
2749797 | Harks | Mar 1950 | A |
3092465 | Adams, Jr. | Jun 1963 | A |
3310002 | Wilburn | Mar 1967 | A |
3620209 | Kravitz | Nov 1971 | A |
3623475 | Sanz et al. | Nov 1971 | A |
3626929 | Sanz et al. | Dec 1971 | A |
3630957 | Rey | Dec 1971 | A |
D223165 | Komendat | Mar 1972 | S |
3723064 | Liotta | Mar 1973 | A |
3741197 | Sanz et al. | Jun 1973 | A |
3961898 | Neeley et al. | Jun 1976 | A |
3992158 | Przybylowicz et al. | Nov 1976 | A |
4014328 | Cluff et al. | Mar 1977 | A |
4042335 | Clement | Aug 1977 | A |
4057394 | Genshaw | Nov 1977 | A |
4109655 | Chacornac | Aug 1978 | A |
4253083 | Imamura | Feb 1981 | A |
4254083 | Columbus | Mar 1981 | A |
4258001 | Pierce et al. | Mar 1981 | A |
4260257 | Neeley et al. | Apr 1981 | A |
4289459 | Neeley et al. | Sep 1981 | A |
4321397 | Nix et al. | Mar 1982 | A |
4350762 | DeLuca et al. | Sep 1982 | A |
4394512 | Batz | Jul 1983 | A |
4414975 | Ryder et al. | Nov 1983 | A |
4416279 | Lindner et al. | Nov 1983 | A |
4418037 | Katsuyama et al. | Nov 1983 | A |
4422941 | Vaughan, Jr. et al. | Dec 1983 | A |
4429700 | Thees et al. | Feb 1984 | A |
4627445 | Garcia et al. | Dec 1986 | A |
4637403 | Garcia et al. | Jan 1987 | A |
4637406 | Guinn et al. | Jan 1987 | A |
4653513 | Dombrowski | Mar 1987 | A |
4661319 | Lape | Apr 1987 | A |
4702261 | Cornell et al. | Oct 1987 | A |
4711250 | Gilbaugh, Jr. et al. | Dec 1987 | A |
4737458 | Batz et al. | Apr 1988 | A |
4767415 | Duffy | Aug 1988 | A |
4774192 | Terminiello et al. | Sep 1988 | A |
4787398 | Garcia et al. | Nov 1988 | A |
4790979 | Terminiello et al. | Dec 1988 | A |
4794926 | Munsch et al. | Jan 1989 | A |
4815843 | Tiefenthaler et al. | Mar 1989 | A |
4829470 | Wang | May 1989 | A |
4844095 | Chiodo et al. | Jul 1989 | A |
4846785 | Cassou et al. | Jul 1989 | A |
4887306 | Hwang et al. | Dec 1989 | A |
4920977 | Haynes | May 1990 | A |
4929426 | Bodai et al. | May 1990 | A |
4930525 | Palestrant | Jun 1990 | A |
4935346 | Phillips | Jun 1990 | A |
4953552 | De Marzo | Sep 1990 | A |
4966646 | Zdeblick | Oct 1990 | A |
4983178 | Schnell | Jan 1991 | A |
4995402 | Smith | Feb 1991 | A |
5029583 | Meserol | Jul 1991 | A |
5035704 | Lambert et al. | Jul 1991 | A |
5049487 | Phillips et al. | Sep 1991 | A |
5050617 | Columbus et al. | Sep 1991 | A |
5059394 | Phillips et al. | Oct 1991 | A |
5077199 | Basagni et al. | Dec 1991 | A |
5094943 | Siedel et al. | Mar 1992 | A |
5110724 | Hewett | May 1992 | A |
5114350 | Hewett | May 1992 | A |
5116759 | Klainer et al. | May 1992 | A |
5131404 | Neeley et al. | Jul 1992 | A |
5141868 | Shanks et al. | Aug 1992 | A |
5145565 | Kater et al. | Sep 1992 | A |
5146437 | Boucheron | Sep 1992 | A |
5153416 | Neeley | Oct 1992 | A |
5164575 | Neeley et al. | Nov 1992 | A |
5166498 | Neeley | Nov 1992 | A |
5174291 | Schoonen et al. | Dec 1992 | A |
5176632 | Bernardi | Jan 1993 | A |
5179005 | Phillips et al. | Jan 1993 | A |
5183741 | Arai et al. | Feb 1993 | A |
5196302 | Kidwell | Mar 1993 | A |
5208163 | Charlton et al. | May 1993 | A |
5213966 | Vuorinen et al. | May 1993 | A |
5217480 | Habar et al. | Jun 1993 | A |
5218966 | Yamasawa | Jun 1993 | A |
5223219 | Subramanian et al. | Jun 1993 | A |
5228972 | Osaka et al. | Jul 1993 | A |
5234818 | Zimmermann et al. | Aug 1993 | A |
5241969 | Carson et al. | Sep 1993 | A |
5251126 | Kahn et al. | Oct 1993 | A |
D341848 | Bigelow et al. | Nov 1993 | S |
5269800 | Davis, Jr. | Dec 1993 | A |
5275159 | Griebel | Jan 1994 | A |
5278079 | Gubinski et al. | Jan 1994 | A |
5288646 | Lundsgaard et al. | Feb 1994 | A |
5299571 | Mastrototaro | Apr 1994 | A |
5301686 | Newman | Apr 1994 | A |
5302513 | Mike et al. | Apr 1994 | A |
5304468 | Phillips et al. | Apr 1994 | A |
5306623 | Kiser et al. | Apr 1994 | A |
5308767 | Terashima | May 1994 | A |
5314441 | Cusack et al. | May 1994 | A |
5320607 | Ishibashi | Jun 1994 | A |
5354537 | Moreno | Oct 1994 | A |
5360595 | Bell et al. | Nov 1994 | A |
5368047 | Suzuki et al. | Nov 1994 | A |
5383512 | Jarvis | Jan 1995 | A |
5390671 | Lord et al. | Feb 1995 | A |
5395388 | Schraga | Mar 1995 | A |
5399316 | Yamada | Mar 1995 | A |
5401110 | Neeley | Mar 1995 | A |
5402798 | Swierczek et al. | Apr 1995 | A |
5426032 | Phillips et al. | Jun 1995 | A |
5441513 | Roth | Aug 1995 | A |
5451350 | Macho et al. | Sep 1995 | A |
5458140 | Eppstein et al. | Oct 1995 | A |
5460777 | Kitajima et al. | Oct 1995 | A |
5460968 | Yoshida et al. | Oct 1995 | A |
5482473 | Lord et al. | Jan 1996 | A |
5506200 | Hirschkoff et al. | Apr 1996 | A |
5507288 | Böcker et al. | Apr 1996 | A |
5508200 | Tiffany et al. | Apr 1996 | A |
5510266 | Bonner et al. | Apr 1996 | A |
5514152 | Smith | May 1996 | A |
5525518 | Lundsgaard et al. | Jun 1996 | A |
5527892 | Borsotti et al. | Jun 1996 | A |
5563042 | Phillips et al. | Oct 1996 | A |
5568806 | Cheney, II et al. | Oct 1996 | A |
5569287 | Tezuka et al. | Oct 1996 | A |
5575403 | Charlton et al. | Nov 1996 | A |
5577499 | Teves | Nov 1996 | A |
5582184 | Erickson et al. | Dec 1996 | A |
5586553 | Halili et al. | Dec 1996 | A |
5591139 | Lin et al. | Jan 1997 | A |
5593838 | Zanzucchi et al. | Jan 1997 | A |
5611809 | Marshall et al. | Mar 1997 | A |
5624458 | Lipscher | Apr 1997 | A |
5630986 | Charlton et al. | May 1997 | A |
5632410 | Moulton et al. | May 1997 | A |
5636632 | Bommannan et al. | Jun 1997 | A |
5647851 | Pokras | Jul 1997 | A |
5658515 | Lee et al. | Aug 1997 | A |
5660791 | Brenneman et al. | Aug 1997 | A |
5670031 | Hintsche et al. | Sep 1997 | A |
5676850 | Reed et al. | Oct 1997 | A |
5680858 | Hansen et al. | Oct 1997 | A |
5681484 | Zanzucchi et al. | Oct 1997 | A |
5682233 | Brinda | Oct 1997 | A |
5697901 | Eriksson | Dec 1997 | A |
5700695 | Yassinzadeh et al. | Dec 1997 | A |
5701181 | Boiarski et al. | Dec 1997 | A |
5701910 | Powles et al. | Dec 1997 | A |
D389761 | Thomas | Jan 1998 | S |
5705018 | Hartley | Jan 1998 | A |
5708247 | McAleer | Jan 1998 | A |
5708787 | Nakano et al. | Jan 1998 | A |
5715417 | Gardien et al. | Feb 1998 | A |
5730753 | Morita | Mar 1998 | A |
5735273 | Kurnik et al. | Apr 1998 | A |
5736103 | Pugh | Apr 1998 | A |
5741211 | Renirie et al. | Apr 1998 | A |
5746217 | Erickson et al. | May 1998 | A |
5746720 | Stouder, Jr. | May 1998 | A |
5757666 | Schreiber et al. | May 1998 | A |
5759364 | Charlton et al. | Jun 1998 | A |
5766066 | Ranniger | Jun 1998 | A |
5771890 | Tamada | Jun 1998 | A |
5797693 | Jaeger | Aug 1998 | A |
5800420 | Gross et al. | Sep 1998 | A |
5801057 | Smart et al. | Sep 1998 | A |
5807375 | Gross et al. | Sep 1998 | A |
5820570 | Erickson et al. | Oct 1998 | A |
5827183 | Kurnik et al. | Oct 1998 | A |
5840020 | Heinonen et al. | Nov 1998 | A |
5841126 | Fossum et al. | Nov 1998 | A |
5843692 | Phillips et al. | Dec 1998 | A |
5846837 | Thym et al. | Dec 1998 | A |
5851215 | Mawhirt et al. | Dec 1998 | A |
5854074 | Charlton et al. | Dec 1998 | A |
D403975 | Douglas et al. | Jan 1999 | S |
5855801 | Lin et al. | Jan 1999 | A |
5856195 | Charlton et al. | Jan 1999 | A |
5858194 | Bell | Jan 1999 | A |
5866281 | Guckel et al. | Feb 1999 | A |
5871494 | Simons et al. | Feb 1999 | A |
5879310 | Sopp et al. | Mar 1999 | A |
5879326 | Godshall et al. | Mar 1999 | A |
5879367 | Latterell et al. | Mar 1999 | A |
5891053 | Sesekura | Apr 1999 | A |
5893870 | Talen et al. | Apr 1999 | A |
5885839 | Lingane et al. | May 1999 | A |
D411621 | Eisenbarth et al. | Jun 1999 | S |
5911711 | Pelkey | Jun 1999 | A |
5911737 | Lee et al. | Jun 1999 | A |
5912139 | Iwata et al. | Jun 1999 | A |
5925021 | Castellano et al. | Jul 1999 | A |
5928207 | Pisano et al. | Jul 1999 | A |
5930873 | Wyser | Aug 1999 | A |
5938679 | Freeman et al. | Aug 1999 | A |
5945678 | Yanagisawa | Aug 1999 | A |
5951492 | Douglas et al. | Sep 1999 | A |
5951493 | Douglas et al. | Sep 1999 | A |
5951521 | Mastrototaro et al. | Sep 1999 | A |
5954685 | Tierney | Sep 1999 | A |
5962215 | Douglas et al. | Oct 1999 | A |
5968760 | Phillips et al. | Oct 1999 | A |
5968765 | Grage et al. | Oct 1999 | A |
5968836 | Matzinger et al. | Oct 1999 | A |
5971941 | Simons et al. | Oct 1999 | A |
5972294 | Smith et al. | Oct 1999 | A |
5986754 | Harding | Nov 1999 | A |
5989409 | Kurnik et al. | Nov 1999 | A |
5993189 | Mueller et al. | Nov 1999 | A |
D417504 | Love et al. | Dec 1999 | S |
6001067 | Shults et al. | Dec 1999 | A |
6005545 | Nishida et al. | Dec 1999 | A |
6010463 | Lauks et al. | Jan 2000 | A |
6010519 | Mawhirt et al. | Jan 2000 | A |
6014135 | Fernandes | Jan 2000 | A |
6014577 | Henning et al. | Jan 2000 | A |
6023629 | Tamada | Feb 2000 | A |
6027459 | Shain et al. | Feb 2000 | A |
6030827 | Davis et al. | Feb 2000 | A |
6032059 | Henning et al. | Feb 2000 | A |
6036924 | Simons et al. | Mar 2000 | A |
6037141 | Banes | Mar 2000 | A |
6041253 | Kost et al. | Mar 2000 | A |
6045753 | Loewy et al. | Apr 2000 | A |
6048352 | Douglas et al. | Apr 2000 | A |
6050988 | Zuck | Apr 2000 | A |
6056701 | Duchon et al. | May 2000 | A |
6056734 | Jacobsen et al. | May 2000 | A |
6058321 | Swayze et al. | May 2000 | A |
6059815 | Lee et al. | May 2000 | A |
6061128 | Zweig et al. | May 2000 | A |
6063039 | Cunningham et al. | May 2000 | A |
6071251 | Cunningham et al. | Jun 2000 | A |
6071294 | Simons et al. | Jun 2000 | A |
6077660 | Wong et al. | Jun 2000 | A |
6080116 | Erickson et al. | Jun 2000 | A |
6083196 | Trautman et al. | Jul 2000 | A |
6086544 | Hibner et al. | Jul 2000 | A |
6090790 | Eriksson | Jul 2000 | A |
6091975 | Daddona et al. | Jul 2000 | A |
6093156 | Cunningham et al. | Jul 2000 | A |
6097831 | Wieck et al. | Aug 2000 | A |
6099484 | Douglas et al. | Aug 2000 | A |
6100107 | Lei et al. | Aug 2000 | A |
6102933 | Lee et al. | Aug 2000 | A |
6103033 | Say et al. | Aug 2000 | A |
6103197 | Werner | Aug 2000 | A |
6106751 | Talbot et al. | Aug 2000 | A |
6118126 | Zanzucchi | Sep 2000 | A |
6120676 | Heller et al. | Sep 2000 | A |
6123861 | Santini, Jr. et al. | Sep 2000 | A |
6126899 | Woudenberg et al. | Oct 2000 | A |
6132449 | Lum et al. | Oct 2000 | A |
6139562 | Mauze et al. | Oct 2000 | A |
6142939 | Eppstein et al. | Nov 2000 | A |
6152942 | Brenneman et al. | Nov 2000 | A |
6162639 | Douglas | Dec 2000 | A |
6172743 | Kley et al. | Jan 2001 | B1 |
6175752 | Say et al. | Jan 2001 | B1 |
6176865 | Mauze et al. | Jan 2001 | B1 |
6183434 | Eppstein et al. | Feb 2001 | B1 |
6183489 | Douglas et al. | Feb 2001 | B1 |
6187210 | Lebouiz et al. | Feb 2001 | B1 |
6192891 | Gravel et al. | Feb 2001 | B1 |
6193873 | Ohara et al. | Feb 2001 | B1 |
6200296 | Dibiasi et al. | Mar 2001 | B1 |
6206841 | Cunningham et al. | Mar 2001 | B1 |
6214626 | Meller et al. | Apr 2001 | B1 |
6219574 | Cormier et al. | Apr 2001 | B1 |
6228100 | Schraga | May 2001 | B1 |
6230051 | Cormier et al. | May 2001 | B1 |
6231531 | Lum et al. | May 2001 | B1 |
6241862 | McAleer et al. | Jun 2001 | B1 |
6242207 | Douglas et al. | Jun 2001 | B1 |
6245215 | Douglas et al. | Jun 2001 | B1 |
6251083 | Yum et al. | Jun 2001 | B1 |
6251260 | Heller et al. | Jun 2001 | B1 |
6254586 | Mann et al. | Jul 2001 | B1 |
6255061 | Mori et al. | Jul 2001 | B1 |
6256533 | Yuzhakov et al. | Jul 2001 | B1 |
6268162 | Phillips et al. | Jul 2001 | B1 |
6271045 | Douglas et al. | Aug 2001 | B1 |
6272364 | Kurnik | Aug 2001 | B1 |
6283926 | Cunningham et al. | Sep 2001 | B1 |
6289230 | Chaiken et al. | Sep 2001 | B1 |
6298254 | Tamada | Oct 2001 | B2 |
6299578 | Kurnik et al. | Oct 2001 | B1 |
6299757 | Feldman et al. | Oct 2001 | B1 |
6306104 | Cunningham et al. | Oct 2001 | B1 |
6309351 | Kurnik et al. | Oct 2001 | B1 |
D450711 | Istvan et al. | Nov 2001 | S |
6312612 | Sherman et al. | Nov 2001 | B1 |
6312812 | Sherman et al. | Nov 2001 | B1 |
6312888 | Wong et al. | Nov 2001 | B1 |
6315738 | Nishikawa et al. | Nov 2001 | B1 |
6322808 | Trautman et al. | Nov 2001 | B1 |
6329161 | Heller et al. | Dec 2001 | B1 |
6331266 | Powell et al. | Dec 2001 | B1 |
6332871 | Douglas et al. | Dec 2001 | B1 |
6334856 | Allen et al. | Jan 2002 | B1 |
6350273 | Minagawa et al. | Feb 2002 | B1 |
6352514 | Douglas et al. | Mar 2002 | B1 |
6356776 | Berner et al. | Mar 2002 | B1 |
6358265 | Thorne, Jr. et al. | Mar 2002 | B1 |
6364890 | Lum et al. | Apr 2002 | B1 |
6375626 | Allen et al. | Apr 2002 | B1 |
6375627 | Mauze et al. | Apr 2002 | B1 |
6379969 | Mauze et al. | Apr 2002 | B1 |
6391005 | Lum et al. | May 2002 | B1 |
6391645 | Huang et al. | May 2002 | B1 |
6402704 | McMorrow | Jun 2002 | B1 |
6409679 | Pyo | Jun 2002 | B2 |
6428664 | BhulLar et al. | Aug 2002 | B1 |
6449608 | Morita et al. | Sep 2002 | B1 |
6455324 | Douglas | Sep 2002 | B1 |
6493069 | Nagashimada et al. | Dec 2002 | B1 |
6500134 | Cassone | Dec 2002 | B1 |
6520973 | McGarry | Feb 2003 | B1 |
6530892 | Kelly | Mar 2003 | B1 |
6537243 | Henning et al. | Mar 2003 | B1 |
6540675 | Aceti et al. | Apr 2003 | B2 |
6544475 | Douglas et al. | Apr 2003 | B1 |
6549796 | Sohrab | Apr 2003 | B2 |
6555061 | Leong et al. | Apr 2003 | B1 |
6558624 | Lemmon et al. | May 2003 | B1 |
6579690 | Bonnecaze et al. | Jun 2003 | B1 |
6589260 | Schmelzeisen-Redeker et al. | Jul 2003 | B1 |
6591125 | Buse et al. | Jul 2003 | B1 |
6602205 | Erickson et al. | Aug 2003 | B1 |
6612111 | Hodges et al. | Sep 2003 | B1 |
6616616 | Fritz et al. | Sep 2003 | B2 |
6626874 | Duchamp | Sep 2003 | B1 |
6656167 | Numao et al. | Dec 2003 | B2 |
6679852 | Schmelzeisen-Redeker et al. | Jan 2004 | B1 |
6706000 | Perez et al. | Mar 2004 | B2 |
6706049 | Moerman | Mar 2004 | B2 |
6706159 | Moerman et al. | Mar 2004 | B2 |
6707554 | Miltner et al. | Mar 2004 | B1 |
6740800 | Cunningham | May 2004 | B1 |
6748275 | Lattner et al. | Jun 2004 | B2 |
6753187 | Cizdziel et al. | Jun 2004 | B2 |
6766817 | da Silva | Jul 2004 | B2 |
6793633 | Douglas et al. | Sep 2004 | B2 |
6830669 | Miyazaki et al. | Dec 2004 | B2 |
6836678 | Tu | Dec 2004 | B2 |
6837858 | Cunningham et al. | Jan 2005 | B2 |
6847451 | Pugh | Jan 2005 | B2 |
6849052 | Uchigaki et al. | Feb 2005 | B2 |
6896850 | Subramanian et al. | May 2005 | B2 |
6918404 | Da Silva | Jul 2005 | B2 |
6919960 | Hansen et al. | Jul 2005 | B2 |
6923764 | Aceti et al. | Aug 2005 | B2 |
6936476 | Anderson et al. | Aug 2005 | B1 |
D511214 | Sasano et al. | Nov 2005 | S |
6988996 | Roe et al. | Jan 2006 | B2 |
7004928 | Aceti et al. | Feb 2006 | B2 |
7011630 | Desai et al. | Mar 2006 | B2 |
7025774 | Freeman et al. | Apr 2006 | B2 |
D519868 | Sasano et al. | May 2006 | S |
7052652 | Zanzucchi et al. | May 2006 | B2 |
7066586 | Da Silva | Jun 2006 | B2 |
7066890 | Lam et al. | Jun 2006 | B1 |
7141058 | Briggs et al. | Nov 2006 | B2 |
7156809 | Quy | Jan 2007 | B2 |
7163616 | Vreeke et al. | Jan 2007 | B2 |
7192061 | Martin | Mar 2007 | B2 |
D540343 | Cummins | Apr 2007 | S |
7223365 | Von Der Goltz | May 2007 | B2 |
7225008 | Ward et al. | May 2007 | B1 |
7226461 | Boecker et al. | Jun 2007 | B2 |
7258673 | Racchini et al. | Aug 2007 | B2 |
D551243 | Young | Sep 2007 | S |
7270970 | Anderson et al. | Sep 2007 | B2 |
7297151 | Boecker et al. | Nov 2007 | B2 |
7299081 | Mace et al. | Nov 2007 | B2 |
7343188 | Sohrab | Mar 2008 | B2 |
7344507 | Briggs et al. | Mar 2008 | B2 |
7379167 | Mawhirt et al. | May 2008 | B2 |
7427377 | Zanzucchi et al. | Sep 2008 | B2 |
D580068 | Shigesada et al. | Nov 2008 | S |
D580558 | Shigesada et al. | Nov 2008 | S |
D599373 | Kobayashi et al. | Sep 2009 | S |
D601257 | Berlinger et al. | Sep 2009 | S |
7585278 | Aceti et al. | Sep 2009 | B2 |
D601444 | Jones et al. | Oct 2009 | S |
D601578 | Poulet et al. | Oct 2009 | S |
7682318 | Alden et al. | Mar 2010 | B2 |
D622393 | Gatrall et al. | Aug 2010 | S |
7780631 | Lum et al. | Aug 2010 | B2 |
7803123 | Perez et al. | Sep 2010 | B2 |
7850621 | Briggs | Dec 2010 | B2 |
7879058 | Ikeda | Feb 2011 | B2 |
7887494 | Emery et al. | Feb 2011 | B2 |
D642191 | Barnett et al. | Jul 2011 | S |
7988644 | Freeman et al. | Aug 2011 | B2 |
8012103 | Escutia et al. | Sep 2011 | B2 |
8012104 | Escutia et al. | Sep 2011 | B2 |
8105849 | McDevitt et al. | Jan 2012 | B2 |
D654926 | Lipman et al. | Feb 2012 | S |
8173439 | Petrich et al. | May 2012 | B2 |
8184273 | Dosmann et al. | May 2012 | B2 |
8231832 | Zanzucchi et al. | Jul 2012 | B2 |
8251920 | Vreeke et al. | Aug 2012 | B2 |
8298255 | Conway et al. | Oct 2012 | B2 |
8303518 | Aceti et al. | Nov 2012 | B2 |
8360993 | Escutia et al. | Jan 2013 | B2 |
8360994 | Escutia et al. | Jan 2013 | B2 |
8372015 | Escutia et al. | Feb 2013 | B2 |
8376959 | Deck | Feb 2013 | B2 |
8382681 | Escutia et al. | Feb 2013 | B2 |
8391940 | Matzinger et al. | Mar 2013 | B2 |
D691174 | Lipman et al. | Oct 2013 | S |
8574168 | Freeman et al. | Nov 2013 | B2 |
8702624 | Alden | Apr 2014 | B2 |
8795201 | Escutia et al. | Aug 2014 | B2 |
8801631 | Escutia et al. | Aug 2014 | B2 |
8919605 | Lipman et al. | Dec 2014 | B2 |
8969097 | Emery et al. | Mar 2015 | B2 |
9060723 | Escutia et al. | Jun 2015 | B2 |
9060727 | Saikley et al. | Jun 2015 | B2 |
9095292 | Zanzucchi et al. | Aug 2015 | B2 |
9149215 | Werner et al. | Oct 2015 | B2 |
9366636 | Emery et al. | Jun 2016 | B2 |
9380974 | Litherland | Jul 2016 | B2 |
9603562 | Aceti et al. | Mar 2017 | B2 |
9636051 | Emery et al. | May 2017 | B2 |
9782114 | Reynolds et al. | Oct 2017 | B2 |
9833183 | Escutia et al. | Dec 2017 | B2 |
9839384 | Escutia et al. | Dec 2017 | B2 |
9897610 | Lipman et al. | Feb 2018 | B2 |
20010001034 | Douglas | May 2001 | A1 |
20010027277 | Klitmose | Oct 2001 | A1 |
20010027328 | Lum et al. | Oct 2001 | A1 |
20010053891 | Ackley | Dec 2001 | A1 |
20020002326 | Causey, III et al. | Jan 2002 | A1 |
20020002344 | Douglas et al. | Jan 2002 | A1 |
20020004640 | Conn et al. | Jan 2002 | A1 |
20020006355 | Whitson | Jan 2002 | A1 |
20020016568 | Lebel et al. | Feb 2002 | A1 |
20020020688 | Sherman et al. | Feb 2002 | A1 |
20020022934 | Vogel et al. | Feb 2002 | A1 |
20020023852 | Mcivor et al. | Feb 2002 | A1 |
20020042594 | Lum et al. | Apr 2002 | A1 |
20020045243 | Laska | Apr 2002 | A1 |
20020052618 | Haar et al. | May 2002 | A1 |
20020087056 | Aceti et al. | Jul 2002 | A1 |
20020136667 | Subramanian et al. | Sep 2002 | A1 |
20020137998 | Smart et al. | Sep 2002 | A1 |
20020160520 | Orloff et al. | Oct 2002 | A1 |
20020168290 | Yuzhakov et al. | Nov 2002 | A1 |
20020169394 | Eppstein et al. | Nov 2002 | A1 |
20020169411 | Sherman et al. | Nov 2002 | A1 |
20020177761 | Orloff et al. | Nov 2002 | A1 |
20020177764 | Sohrab | Nov 2002 | A1 |
20020183102 | Withers et al. | Dec 2002 | A1 |
20020188223 | Perez et al. | Dec 2002 | A1 |
20020198444 | Uchigaki et al. | Dec 2002 | A1 |
20030012693 | Otillar et al. | Jan 2003 | A1 |
20030028087 | Yuzhakov et al. | Feb 2003 | A1 |
20030028125 | Yuzhakov et al. | Feb 2003 | A1 |
20030039587 | Niermann | Feb 2003 | A1 |
20030060730 | Perez | Mar 2003 | A1 |
20030083685 | Freeman et al. | May 2003 | A1 |
20030083686 | Freeman et al. | May 2003 | A1 |
20030105961 | Zatloukal et al. | Jun 2003 | A1 |
20030116596 | Terasawa | Jun 2003 | A1 |
20030135166 | Gonnelli | Jul 2003 | A1 |
20030135333 | Aceti | Jul 2003 | A1 |
20030143746 | Sage | Jul 2003 | A1 |
20030153844 | Smith et al. | Aug 2003 | A1 |
20030153900 | Aceti et al. | Aug 2003 | A1 |
20030175987 | Verdonk et al. | Sep 2003 | A1 |
20030206302 | Pugh | Nov 2003 | A1 |
20030207441 | Eyster et al. | Nov 2003 | A1 |
20030208113 | Mault et al. | Nov 2003 | A1 |
20030211619 | Olson et al. | Nov 2003 | A1 |
20030212344 | Yuzhakov et al. | Nov 2003 | A1 |
20030212345 | McAllister et al. | Nov 2003 | A1 |
20030212347 | Sohrab | Nov 2003 | A1 |
20030216628 | Bortz et al. | Nov 2003 | A1 |
20040010207 | Flaherty et al. | Jan 2004 | A1 |
20040030353 | Schmelzeisen-Redeker et al. | Feb 2004 | A1 |
20040039303 | Wurster et al. | Feb 2004 | A1 |
20040049219 | Briggs et al. | Mar 2004 | A1 |
20040059256 | Perez | Mar 2004 | A1 |
20040072357 | Stiene et al. | Apr 2004 | A1 |
20040073140 | Douglas | Apr 2004 | A1 |
20040092842 | Boecker et al. | May 2004 | A1 |
20040092995 | Boecker et al. | May 2004 | A1 |
20040094432 | Neel et al. | May 2004 | A1 |
20040096959 | Stiene et al. | May 2004 | A1 |
20040097796 | Berman et al. | May 2004 | A1 |
20040098009 | Boecker et al. | May 2004 | A1 |
20040102803 | Boecker et al. | May 2004 | A1 |
20040122339 | Roe et al. | Jun 2004 | A1 |
20040132167 | Rule et al. | Jul 2004 | A1 |
20040138588 | Saikley et al. | Jul 2004 | A1 |
20040155084 | Brown | Aug 2004 | A1 |
20040178218 | Schomakers et al. | Sep 2004 | A1 |
20040186394 | Roe et al. | Sep 2004 | A1 |
20040191119 | Zanzucchi et al. | Sep 2004 | A1 |
20040202576 | Aceti et al. | Oct 2004 | A1 |
20040230216 | Levaughn et al. | Nov 2004 | A1 |
20040236251 | Roe et al. | Nov 2004 | A1 |
20040238675 | Banaszkiewicz et al. | Dec 2004 | A1 |
20040242982 | Sakata et al. | Dec 2004 | A1 |
20040249253 | Racchini et al. | Dec 2004 | A1 |
20040259180 | Burke et al. | Dec 2004 | A1 |
20050004494 | Perez et al. | Jan 2005 | A1 |
20050010134 | Douglas et al. | Jan 2005 | A1 |
20050015020 | LeVaughn et al. | Jan 2005 | A1 |
20050027182 | Siddiqui et al. | Feb 2005 | A1 |
20050038680 | McMahon | Feb 2005 | A1 |
20050070819 | Poux et al. | Mar 2005 | A1 |
20050096686 | Allen | May 2005 | A1 |
20050106713 | Phan et al. | May 2005 | A1 |
20050109386 | Marshall | May 2005 | A1 |
20050159678 | Taniike et al. | Jul 2005 | A1 |
20050187532 | Thurau et al. | Aug 2005 | A1 |
20050192492 | Cho et al. | Sep 2005 | A1 |
20050202567 | Zanzucchi et al. | Sep 2005 | A1 |
20050202733 | Yoshimura et al. | Sep 2005 | A1 |
20050209518 | Sage, Jr. et al. | Sep 2005 | A1 |
20050215872 | Berner et al. | Sep 2005 | A1 |
20050215923 | Wiegel | Sep 2005 | A1 |
20050234494 | Conway | Oct 2005 | A1 |
20050245844 | Mace et al. | Nov 2005 | A1 |
20050255001 | Padmaabhan et al. | Nov 2005 | A1 |
20050277972 | Wong et al. | Dec 2005 | A1 |
20060008389 | Sacherer et al. | Jan 2006 | A1 |
20060036134 | Tarassenko et al. | Feb 2006 | A1 |
20060052724 | Roe | Mar 2006 | A1 |
20060064035 | Wang et al. | Mar 2006 | A1 |
20060094985 | Aceti et al. | May 2006 | A1 |
20060117616 | Jones et al. | Jun 2006 | A1 |
20060135873 | Karo et al. | Jun 2006 | A1 |
20060155317 | List | Jul 2006 | A1 |
20060178600 | Kennedy et al. | Aug 2006 | A1 |
20060189908 | Kennedy | Aug 2006 | A1 |
20060204399 | Freeman et al. | Sep 2006 | A1 |
20060229533 | Hoenes et al. | Oct 2006 | A1 |
20060241517 | Fowler et al. | Oct 2006 | A1 |
20060257993 | Mcdevitt et al. | Nov 2006 | A1 |
20060259102 | Slatkine | Nov 2006 | A1 |
20060281187 | Emery et al. | Dec 2006 | A1 |
20070016104 | Jansen et al. | Jan 2007 | A1 |
20070017824 | Rippeth et al. | Jan 2007 | A1 |
20070078313 | Emery et al. | Apr 2007 | A1 |
20070078358 | Escutia et al. | Apr 2007 | A1 |
20070083131 | Escutia et al. | Apr 2007 | A1 |
20070112281 | Olson | May 2007 | A1 |
20070179404 | Escutia et al. | Aug 2007 | A1 |
20070179405 | Litherland et al. | Aug 2007 | A1 |
20070253531 | Okuzawa et al. | Nov 2007 | A1 |
20070255181 | Alvarez-icaza et al. | Nov 2007 | A1 |
20070255302 | Koeppel et al. | Nov 2007 | A1 |
20080046831 | Imai et al. | Feb 2008 | A1 |
20080077048 | Escutia et al. | Mar 2008 | A1 |
20080139910 | Mastrototaro | Jun 2008 | A1 |
20080194934 | Ray et al. | Aug 2008 | A1 |
20080269625 | Halperin et al. | Oct 2008 | A1 |
20090054810 | Zanzucchi et al. | Feb 2009 | A1 |
20090156923 | Power et al. | Jun 2009 | A1 |
20090292489 | Burke et al. | Nov 2009 | A1 |
20090301899 | Hodges et al. | Dec 2009 | A1 |
20100010374 | Escutia et al. | Jan 2010 | A1 |
20100021947 | Emery et al. | Jan 2010 | A1 |
20100021948 | Lipman et al. | Jan 2010 | A1 |
20100095229 | Dixon et al. | Apr 2010 | A1 |
20100174211 | Frey et al. | Jul 2010 | A1 |
20100185120 | Sacherer et al. | Jul 2010 | A1 |
20100217155 | Poux et al. | Aug 2010 | A1 |
20100331650 | Batman et al. | Dec 2010 | A1 |
20110098599 | Emery et al. | Apr 2011 | A1 |
20110105872 | Chickering, III et al. | May 2011 | A1 |
20110201909 | Emery et al. | Aug 2011 | A1 |
20110294152 | Lipman et al. | Dec 2011 | A1 |
20120166090 | Lipman et al. | Jun 2012 | A1 |
20130110516 | Abulhaj et al. | May 2013 | A1 |
20130158430 | Aceti et al. | Jun 2013 | A1 |
20130158432 | Escutia et al. | Jun 2013 | A1 |
20130172698 | Reynolds et al. | Jul 2013 | A1 |
20130274568 | Escutia et al. | Oct 2013 | A1 |
20130274579 | Richter et al. | Oct 2013 | A1 |
20140316301 | Escutia et al. | Oct 2014 | A1 |
20140376762 | Lipman et al. | Dec 2014 | A1 |
20150037898 | Baldus et al. | Feb 2015 | A1 |
20150153351 | Lipman et al. | Jun 2015 | A1 |
20150212006 | Emery et al. | Jul 2015 | A1 |
20160038066 | Escutia et al. | Feb 2016 | A1 |
20170095188 | Emery et al. | Apr 2017 | A1 |
20170319121 | Aceti et al. | Nov 2017 | A1 |
20170354355 | Emery et al. | Dec 2017 | A1 |
20180008178 | Escutia et al. | Jan 2018 | A1 |
20180214059 | Escutia et al. | Aug 2018 | A1 |
20180296143 | Anderson et al. | Oct 2018 | A1 |
20180310865 | Escutia et al. | Nov 2018 | A1 |
Number | Date | Country |
---|---|---|
2 201 530 | Sep 1997 | CA |
2 513 465 | Aug 2004 | CA |
197 05 091 | Feb 1999 | DE |
199 22 413 | Nov 2000 | DE |
103 02-501 | Aug 2004 | DE |
0 103 426 | Mar 1984 | EP |
0 256 806 | Feb 1988 | EP |
0 396-016 | Nov 1990 | EP |
0 397 424 | Nov 1990 | EP |
0 255-338 | Feb 1998 | EP |
0 849 584 | Jun 1998 | EP |
1 266-607 | Dec 2002 | EP |
1 369 688 | Oct 2003 | EP |
1 360-934 | Nov 2003 | EP |
1 486-766 | Dec 2004 | EP |
1 529-489 | May 2005 | EP |
1 769-735 | Apr 2007 | EP |
63-305841 | Dec 1988 | JP |
3-63570 | Mar 1991 | JP |
03093189 | Apr 1991 | JP |
7-67861 | Mar 1995 | JP |
7-213925 | Aug 1995 | JP |
9-168530 | Jun 1997 | JP |
9-266889 | Oct 1997 | JP |
9-294737 | Nov 1997 | JP |
9-313465 | Dec 1997 | JP |
10-024028 | Jan 1998 | JP |
10-505258 | May 1998 | JP |
10-508518 | Aug 1998 | JP |
10-318970 | Dec 1998 | JP |
11-056822 | Mar 1999 | JP |
11-281779 | Oct 1999 | JP |
2000-116629 | Apr 2000 | JP |
2000-126161 | May 2000 | JP |
2000-168754 | Jun 2000 | JP |
2000-254111 | Sep 2000 | JP |
2001-159618 | Jun 2001 | JP |
2001-515203 | Sep 2001 | JP |
2001-305096 | Oct 2001 | JP |
2001-330581 | Nov 2001 | JP |
2002-502045 | Jan 2002 | JP |
2002-085384 | Mar 2002 | JP |
2002-514453 | May 2002 | JP |
2002-168862 | Jun 2002 | JP |
2003-507719 | Feb 2003 | JP |
2003-108679 | Apr 2003 | JP |
2003-180417 | Jul 2003 | JP |
2004-000598 | Jan 2004 | JP |
2004-500948 | Jan 2004 | JP |
2004-117339 | Apr 2004 | JP |
2004-202256 | Jul 2004 | JP |
2004-209266 | Jul 2004 | JP |
2004-519302 | Jul 2004 | JP |
2004-522500 | Jul 2004 | JP |
2004-528936 | Sep 2004 | JP |
2005-009238 | Feb 2005 | JP |
2005-503538 | Feb 2005 | JP |
2005-087613 | Apr 2005 | JP |
3638958 | Apr 2005 | JP |
2005-525149 | Aug 2005 | JP |
2005-237938 | Sep 2005 | JP |
2005-525846 | Sep 2005 | JP |
2005-527254 | Sep 2005 | JP |
2006-506185 | Feb 2006 | JP |
2006-512969 | Apr 2006 | JP |
2006-512974 | Apr 2006 | JP |
2006-516723 | Jul 2006 | JP |
2006-521555 | Sep 2006 | JP |
2006-527013 | Nov 2006 | JP |
2007-014381 | Jan 2007 | JP |
2007-054407 | Mar 2007 | JP |
2007-067698 | Mar 2007 | JP |
2007-136198 | Jun 2007 | JP |
2007-521031 | Aug 2007 | JP |
2007-527287 | Sep 2007 | JP |
2007-311196 | Nov 2007 | JP |
2007-537804 | Dec 2007 | JP |
2008-125813 | Jun 2008 | JP |
2008-212324 | Sep 2008 | JP |
2009-509645 | Mar 2009 | JP |
2009-509667 | Mar 2009 | JP |
WO-8605966 | Oct 1986 | WO |
WO-8800812 | Feb 1988 | WO |
WO-8807666 | Oct 1988 | WO |
WO-9114212 | Sep 1991 | WO |
WO-9413203 | Jun 1994 | WO |
WO-9510223 | Apr 1995 | WO |
WO-9510223 | Apr 1995 | WO |
WO-9604857 | Feb 1996 | WO |
WO-9607907 | Mar 1996 | WO |
WO-9614026 | May 1996 | WO |
WO-9625088 | Aug 1996 | WO |
WO-9704707 | Feb 1997 | WO |
WO-9715227 | May 1997 | WO |
WO-9729847 | Aug 1997 | WO |
WO-9730344 | Aug 1997 | WO |
WO-9741421 | Nov 1997 | WO |
WO-9742885 | Nov 1997 | WO |
WO-9742888 | Nov 1997 | WO |
WO-9743962 | Nov 1997 | WO |
WO-9800193 | Jan 1998 | WO |
WO-9831275 | Jul 1998 | WO |
WO-9835225 | Aug 1998 | WO |
WO-9912008 | Mar 1999 | WO |
WO-9923492 | May 1999 | WO |
WO-9944508 | Sep 1999 | WO |
WO-9956954 | Nov 1999 | WO |
WO-9958051 | Nov 1999 | WO |
WO-0009184 | Feb 2000 | WO |
WO-0013573 | Mar 2000 | WO |
WO-0014269 | Mar 2000 | WO |
WO-0014535 | Mar 2000 | WO |
WO-0018449 | Apr 2000 | WO |
WO-0018449 | Apr 2000 | WO |
WO-0019185 | Apr 2000 | WO |
WO-0036400 | Jun 2000 | WO |
WO-0042422 | Jul 2000 | WO |
WO-0074763 | Dec 2000 | WO |
WO-0074763 | Dec 2000 | WO |
WO-0078208 | Dec 2000 | WO |
WO-0113795 | Mar 2001 | WO |
WO-0116575 | Mar 2001 | WO |
WO-0152727 | Jul 2001 | WO |
WO-0164105 | Sep 2001 | WO |
WO-0164105 | Sep 2001 | WO |
WO-0172220 | Oct 2001 | WO |
WO-0180728 | Nov 2001 | WO |
WO-0185233 | Nov 2001 | WO |
WO-0185233 | Nov 2001 | WO |
WO-0191634 | Dec 2001 | WO |
WO-0191634 | Dec 2001 | WO |
WO-0200101 | Jan 2002 | WO |
WO-0200101 | Jan 2002 | WO |
WO-0249507 | Jun 2002 | WO |
WO-0249509 | Jun 2002 | WO |
WO-0249509 | Jun 2002 | WO |
WO-02078533 | Oct 2002 | WO |
WO-02078533 | Oct 2002 | WO |
WO-02082052 | Oct 2002 | WO |
WO-02082052 | Oct 2002 | WO |
WO-02093144 | Nov 2002 | WO |
WO-02100251 | Dec 2002 | WO |
WO-02100251 | Dec 2002 | WO |
WO-02101359 | Dec 2002 | WO |
WO-02101359 | Dec 2002 | WO |
WO-2003030984 | Apr 2003 | WO |
WO-2003066128 | Aug 2003 | WO |
WO-2003066128 | Aug 2003 | WO |
WO-2003070099 | Aug 2003 | WO |
WO-2003071940 | Sep 2003 | WO |
WO-2003071940 | Sep 2003 | WO |
WO-2004045375 | Jun 2004 | WO |
WO-2004045375 | Jun 2004 | WO |
WO-2004062499 | Jul 2004 | WO |
WO-2004062500 | Jul 2004 | WO |
WO-2004062500 | Jul 2004 | WO |
WO-2004064636 | Aug 2004 | WO |
WO-2004085995 | Oct 2004 | WO |
WO-2004085995 | Oct 2004 | WO |
WO-2004091693 | Oct 2004 | WO |
WO-2004091693 | Oct 2004 | WO |
WO-2004105827 | Dec 2004 | WO |
WO-2004105827 | Dec 2004 | WO |
WO-2005006939 | Jan 2005 | WO |
WO-2005006939 | Jan 2005 | WO |
WO-2005009238 | Feb 2005 | WO |
WO-2005013824 | Feb 2005 | WO |
WO2005016125 | Feb 2005 | WO |
WO-2005018709 | Mar 2005 | WO |
WO-2005018709 | Mar 2005 | WO |
WO-2005018710 | Mar 2005 | WO |
WO-2005018710 | Mar 2005 | WO |
WO-2005084543 | Sep 2005 | WO |
WO-2005084546 | Sep 2005 | WO |
WO-2005084546 | Sep 2005 | WO |
WO-2005085995 | Sep 2005 | WO |
WO-2005090969 | Sep 2005 | WO |
WO-2005112763 | Dec 2005 | WO |
WO-2006138226 | Dec 2006 | WO |
WO-2006138226 | Dec 2006 | WO |
WO-2007041062 | Apr 2007 | WO |
WO-2007041062 | Apr 2007 | WO |
WO-2007041063 | Apr 2007 | WO |
WO-2007041063 | Apr 2007 | WO |
WO-2007041244 | Apr 2007 | WO |
WO-2007041244 | Apr 2007 | WO |
WO-2007041287 | Apr 2007 | WO |
WO-2007041287 | Apr 2007 | WO |
WO-2007041355 | Apr 2007 | WO |
WO-2007041355 | Apr 2007 | WO |
WO-2007108519 | Sep 2007 | WO |
WO-2007112034 | Oct 2007 | WO |
WO-2007112034 | Oct 2007 | WO |
WO-2008027319 | Mar 2008 | WO |
WO-2008027319 | Mar 2008 | WO |
WO-2008062648 | May 2008 | WO |
WO-2009145920 | Dec 2009 | WO |
WO-2009148624 | Dec 2009 | WO |
WO-2009148626 | Dec 2009 | WO |
WO-2011065981 | Jun 2011 | WO |
WO-2011162823 | Dec 2011 | WO |
WO-2013020103 | Feb 2013 | WO |
WO-2014205412 | Dec 2014 | WO |
WO-2018191700 | Oct 2018 | WO |
Entry |
---|
ADA Consensus Development Panel. (Jan.-Feb. 1987). “Consensus Statement on Self-Monitoring of Blood Glucose,” Diabetes Care 10(1):95-99. |
ADA (Jan. 1994). “Self-Monitoring of Blood Glucose,” Consensus Statement Diabetes Care 17(1):81-86. |
Anonymous. (Sep. 30, 1993). “The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus.” The New England Journal of Medicine 329(14):977-986. |
Anonymous. (Jun. 23, 1998). “Taking the “Ouch” Out of Needles: Arrays of “Microneedles” Offer New Techniques for Drug Delivery,” Science Daily, located at <http:www.sciencedaily.com/releases/1998/06/980623045850.htm>, last visited Jan. 14, 2014, 3 pages. |
Beregszászi, M. et al. (Jul. 1997). “Nocturnal Hypoglycemia in Children and Adolescents with Insulin-Dependent Diabetes Mellitus: Prevalence and Risk Factors,” J. Pediatrics 131(1 Pt. 1):27-33. |
Brazzle, J. et al. Active Microneedles with Integrated Functionality, Solid-State Sensor and Actuator Workshop, Hilton Head Island, South Carolina, Jun. 4-8, 2000, Technical Digest, 199-202. |
Burge, M.R., (Aug. 2001). “Lack of Compliance with Home Blood Glucose Monitoring Predicts Hospitalization in Diabetes”, Diabetes Care 24(8): 1502-1503. |
Chase, H.P. et al. (Feb. 2001). “Continuous Subcutaneous Glucose Monitoring in Children with Type 1 Diabetes,” Pediatrics 107(2):222-226. |
Clarke, W.L. et al. (Sep.-Oct. 1987). “Evaluating Clinical Accuracy of Systems for Self-Monitoring of Blood Glucose,” Diabetes Care 10(5):622-628. |
Clarke, W.L. et al. (Sep.-Oct. 1981). “Evaluation of a New Reflectance Photometer for Use in Home Blood Glucose Monitoring,” Diabetes Care, 4(5):547-550. |
Collison, M.E. et al. (Sep. 1999). “Analytical Characterization of Electrochemical Biosensor Test Strips for Measurement of Glucose in Low-Volume Interstitial Fluid Samples,” Clinical Chemistry 45(9):1665-1673. |
Coster, S. et al. (2000). “Monitoring Blood Glucose Control in Diabetes Mellitus: A Systematic Review.” Health Technology Assessment 4(12):1-93. |
Cox, D.J. et al. (Jun. 1997). “Understanding Error Grid Analysis,” Diabetes Care 20(6):911-912. |
D'Arrigo, T.D. (Mar. 2000). “GlucoWatch Monitor Poised for Approval,” Diabetes Forecast, 53(3):43-44. |
Extended European Search Report dated Apr. 29, 2013 for EP Patent Application No. 12192620.8, filed on Nov. 14, 2012, 8 pages. |
Extended European Search Report dated Feb. 2, 2016 for European Patent Application No. 15187274.4, filed on Sep. 29, 2015, 5 pages. |
Extended European Search Report dated Jan. 22, 2013, for EP Application No. 12182900.6, filed on Sep. 29, 2006, 6 pages. |
Extended European Search Report dated Feb. 22, 2012, for EP Application No. EP 10 18 1155, filed Sep. 28, 2010, six pages. |
Extended European Search Report dated Jul. 18, 2013, for EP Application No. 06 772 943.4, filed on Jun. 13, 2006, 7 pages. |
Extended European Search Report dated Nov. 8, 2016, for EP Application No. 16 167 087.2, filed on Aug. 3, 2012, 6 pages. |
Extended European Search Report dated Apr. 19, 2011, for EP Application No. 10 18 0848.3 filed Sep. 28, 2010, 5 pages. |
Feldman, B. et al. (2000). “FreeStyle™: A Small-Volume Electrochemical Glucose Sensor for Home Blood Glucose Testing,” Diabetes Technology and Therapeutics, 2(2):221-229. |
Final Office Action dated Jul. 9, 2008, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 19 pages. |
Final Office Action dated Nov. 23, 2009, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 20 pages. |
Final Office Action dated Jan. 21, 2011, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 7 pages. |
Final Office Action dated Aug. 15, 2013 for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 12 pages. |
Final Office Action dated Apr. 13, 2016, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 31 pages. |
Final Office Action dated Aug. 28, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 11 pages. |
Final Office Action dated Dec. 26, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 9 pages. |
Final Office Action dated Jan. 22, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages. |
Final Office Action dated Jun. 30, 2010, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 11 pages. |
Final Office Action dated May 30, 2007, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 11 pages. |
Final Office Action dated Nov. 1, 2010, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 9 pages. |
Final Office Action dated Nov. 21, 2011, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 8 pages. |
Final Office Action dated Jun. 11, 2010, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 16 pages. |
Final Office Action dated Mar. 10, 2015, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 24 pages. |
Final Office Action dated Oct. 15, 2009, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 13 pages. |
Final Office Action dated Aug. 14, 2012, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages. |
Final Office Action dated Sep. 23, 2013, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages. |
Final Office Action dated Mar. 5, 2009, for U.S. Appl. No. 11/239,123, filed Sep. 30, 2005, 17 pages. |
Final Office Action dated Mar. 3, 2011, for U.S. Appl. No. 11/239,123, filed Sep. 30, 2005, 25 pages. |
Final Office Action dated Jan. 6, 2016, for U.S. Appl. No. 14/321,631, filed Jul. 1, 2014, 9 pages. |
Hemmerich, K.J. et al. (Apr. 1995).“Guide to Engineering Thermoplastics,” Medical Devices and Diagnostic Industry pp. 39-59. |
International Search Report dated Aug. 16, 2007 for PCT Application No. PCT/US2006/038163, filed on Sep. 29, 2006, 1 page. |
International Search Report dated Dec. 3, 2004, for PCT Application No. PCT/US2004/08798, filed on Mar. 24, 2004, 3 pages. |
International Search Report dated Aug. 17, 2007 for PCT/US2006/38049, filed on Sep. 29, 2006, 1 page. |
International Search Report dated Oct. 19, 2012 for PCT Application No. PCT/US2012/049629, filed on Aug. 3, 2012, 4 pages. |
International Search Report dated Jan. 16, 2008, for PCT Application No. PCT/US2006/022840, filed on Jun. 13, 2006, 1 page. |
International Search Report dated Aug. 20, 2007 for PCT Application No. PCT/US2006/37245, filed on Sep. 26, 2006, 1 page. |
International Search Report dated May 2, 2007, for PCT Application No. PCT/US2006/37923, filed on Sep. 9, 2006, 1 page. |
INTEG. (2000). “LifeGuide™ Glucose Meter. No Lancets. No Blood,” located at <http://www.integonline.com>, last visited May 1, 2000, 10 pages. |
Ishii H. et al., (Aug. 2001). “Seasonal Variation of Glycemic Control in Type 2 Diabetic Patients”, Diabetes Care 24(8):1503. |
Johnson, R.N. et al. (Jan. 1998). “Accuracy of Devices Used for Self-Monitoring of Blood Glucose,” Annals of Clinical Biochemistry 35(1):68-74. |
Johnson, R.N. et al. (Jan. 1999). “Analytical Error of Home Glucose Monitors: A Comparison of 18 Systems,” Annals of Clinical Biochemistry 36(1):72-79. |
Johnson, R.N. et al. (2001). “Error Detection and Measurement in Glucose Monitors,” Clinica Chimica Acta 307:61-67. |
KUMETRIX, Inc. (Dec. 1999). “Painless Blood Glucose Monitoring, Courtesy of the Mosquito,” Start-Up pp. 27-28. |
Lee, S-C. (Jun. 1999). “Light Scattering by Closely Spaced Parallel Cylinders Embedded in a Finite Dielectric Slab,” Journal of the Optical Society of America A 16(6):1350-1361. |
McGarraugh, G. et al. (2001). “Physiological Influences on Off-Finger Glucose Testing,” Diabetes Technology & Therapeutics 3(3):367-376. |
McNichols, R.J. et al. (Jan. 2000). “Optical Glucose Sensing in Biological Fluids: An Overview,” Journal of Biomedical Optics, 5(1):5-16. |
Mahler, R.J. et al. (1999). “Clinical Review 102, Type 2 Diabetes Mellitus: Update on Diagnosis Pathophysiology, and Treatment,” The Journal of Clinical Endocrinology and Metabolism 84(4):1165-1171. |
Massey V. et al. (Aug. 1960). “Studies on the Reaction Mechanism of Lipoyl Dehydrogenase” Biochim. Biophys. Acta 48: 33-47. |
Medline Plus. (Jun. 17, 2008). , Medical Encyclopedia, Monitor Blood Glucose-Series: Part 1-4, 6 pages. |
Neeley, W.E. et al. (1981). “An Instrument for Digital Matrix Photometry,” Clinical Chemistry 27(10):1665-1668. |
Neeley, W.E. (1983). “Reflectance Digital Matrix Photometry,” Clinical Chemistry 29(6):1038-1041. |
Neeley, W.E. (1983). “Multilayer Film Analysis for Glucose in 1-μL Samples of Plasma,” Clinical Chemistry 29(12):2103-2105. |
Neeley, W.E. (1988). “A Reflectance Photometer with a Square Photodiode Array Detector for Use on Multilayer Dry-Film Slides,” Clinical Chemistry 34(11):2367-2370. |
Non-Final Office Action dated Apr. 10, 2014, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages. |
Non-Final Office Action dated May 29, 2015, for U.S. Appl. No. 14/614,177, filed Feb. 4, 2015, 13 pages. |
Non Final Office Action dated Aug. 5, 2014, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages. |
Non-Final Office Action dated Dec. 12, 2007, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 13 pages. |
Non-Final Office Action dated Apr. 28, 2009, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 21 pages. |
Non-Final Office Action dated Jun. 4, 2010, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 23 pages. |
Non-Final Office Action dated Mar. 23, 2012, for U.S. Appl. No. 13/197,592, filed Aug. 3, 2011, 7 pages. |
Non-Final Office Action dated Mar. 23, 2012, for U.S. Appl. No. 13/197,603, filed Aug. 3, 2011, 6 pages. |
Non-Final Office Action dated Nov. 26, 2012 for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 9 pages. |
Non Final Office Action dated Apr. 8, 2015, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 11 pages. |
Non-Final Office Action dated Mar. 19, 2009, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 15 pages. |
Non-Final Office Action dated Sep. 1, 2010, for U.S. Appl. No. 11/239,122, filed Sep. 30, 2005, 15 pages. |
Non Final Office Action dated Apr. 12, 2011, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 7 pages. |
Non-Final Office Action dated Sep. 13, 2011, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 14 pages. |
Non-Final Office Action dated Feb. 28, 2013, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 12 pages. |
Non Final Office Action dated Dec. 5, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 7 pages. |
Non Final Office Action dated Jan. 12, 2009, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages. |
Non Final Office Action dated Jan. 21, 2011, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages. |
Non Final Office Action dated Jul. 13, 2010, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 11 pages. |
Non Final Office Action dated Jul. 31, 2015, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 16 pages. |
Non Final Office Action dated Mar. 21, 2014, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 12 pages. |
Non Final Office Action dated Mar. 25, 2011, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 13 pages. |
Non Final Office Action dated Mar. 5, 2010, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 8 pages. |
Non Final Office Action dated May 14, 2008, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 9 pages. |
Non Final Office Action dated May 16, 2013, for U.S. Appl. No. 13/669,366, filed Nov. 5, 2012, 8 pages. |
Non Final Office Action dated May 5, 2005, for U.S. Appl. No. 10/131,268, filed Apr. 23, 2002, 8 pages. |
Non Final Office Action dated Nov. 2, 2006, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 10 pages. |
Non Final Office Action dated Oct. 14, 2009, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 10 pages. |
Non Final Office Action dated Oct. 3, 2008, for U.S. Appl. No. 10/722,074, filed Nov. 24, 2003, 10 pages. |
Non-Final Office Action dated Dec. 17, 2015, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 6 pages. |
Non Final Office Action dated Dec. 2, 2004, for U.S. Appl. No. 10/347,620, filed Jan. 22, 2003, 8 pages. |
Non-Final Office Action dated Jan. 27, 2009, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 17 pages. |
Non-Final Office Action dated Jan. 6, 2014, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 12 pages. |
Non-Final Office Action dated Jun. 21, 2013, for U.S. Appl. No. 13/752,261, filed Jan. 28, 2013, 12 pages. |
Non-Final Office Action dated Jun. 6, 2008, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 17 pages. |
Non-Final Office Action dated Oct. 9, 2014, for U.S. Appl. No. 14/446,262, filed Jul. 29, 2014, 15 pages. |
Non Final Office Action dated Sep. 29, 2004, for U.S. Appl. No. 10/394,230, filed Mar. 24, 2003, 10 pages. |
Non-Final Office Action dated Nov. 1, 2007, for U.S. Appl. No. 11/239,123, filed Sep. 30, 2005, 15 pages. |
Non-Final Office Action dated Apr. 15, 2010, for U.S. Appl. No. 11/239,123, filed Sep. 30, 2005, 19 pages. |
Non-Final Office Action dated Sep. 19, 2013, for U.S. Appl. No. 11/239,123, filed Sep. 30, 2005, 24 pages. |
Non-Final Office Action dated Aug. 8, 2014, for U.S. Appl. No. 14/321,631, filed Jul. 1, 2014, 11 pages. |
Notice of Allowance dated Apr. 3, 2014, for U.S. Appl. No. 11/239,123, filed Sep. 30, 2005, 6 pages. |
Notice of Allowance dated Apr. 18, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 8 pages. |
Notice of Allowance dated Apr. 19, 2010, for U.S. Appl. No. 29/338,117, filed Jun. 4, 2009, 4 pages. |
Notice of Allowance dated Aug. 3, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 5 pages. |
Notice of Allowance dated Jan. 14, 2010, for U.S. Appl. No. 29/338,117, filed Jun. 4, 2009, 4 pages. |
Notice of Allowance dated Jun. 29, 2012, for U.S. Appl. No. 11/311,667, filed Dec. 20, 2005, 5 pages. |
Notice of Allowance dated Mar. 14, 2012, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 7 pages. |
Notice of Allowance dated Mar. 31, 2005, for U.S. Appl. No. 10/394,230, filed Mar. 24, 2003, 10 pages. |
Notice of Allowance dated May 15, 2008, for U.S. Appl. No. 11/125,107, filed May 10, 2005, 7 pages. |
Notice of Allowance dated May 18, 2009, for U.S. Appl. No. 29/300,934, filed May 30, 2008, 4 pages. |
Notice of Allowance dated Nov. 23, 2011, for U.S. Appl. No. 12/222,724, filed Aug. 14, 2008, 7 pages. |
Notice of Allowance dated Nov. 27, 2012, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 5 pages. |
Notice of Allowance dated Nov. 29, 2005, for U.S. Appl. No. 10/131,268, filed Apr. 23, 2002, 6 pages. |
Notice of Allowance dated Oct. 12, 2011, for U.S. Appl. No. 11/529,612, filed Sep. 29, 2006, 8 pages. |
Notice of Allowance dated Feb. 23, 2015, for U.S. Appl. No. 14/446,262, filed Jul. 29, 2014, 8 pages. |
Notice of Allowance dated Feb. 5, 2014, for U.S. Appl. No. 13/752,261, filed Jan. 28, 2013, 9 pages. |
Notice of Allowance dated Jun. 15, 2009, for U.S. Appl. No. 10/722,074, filed Nov. 24, 2003, 6 pages. |
Notice of Allowance dated Mar. 2, 2016, for U.S. Appl. No. 11/529,614, filed Sep. 29, 2006, 12 pages. |
Notice of Allowance dated Mar. 28, 2005, for U.S. Appl. No. 10/347,620, filed Jan. 22, 2003, 6 pages. |
Notice of Allowance dated Sep. 18, 2014, for U.S. Appl. No. 13/037,089, filed Feb. 28, 2011, 9 pages. |
Notice of Allowance dated Feb. 16, 2016, for U.S. Appl. No. 14/614,177, filed Feb. 4, 2015, 7 pages. |
Notice of Allowance dated May 3, 2011, for U.S. Appl. No. 11/529,613, filed Sep. 29, 2006, 12 pages. |
Notice of Allowance dated Mar. 27, 2015, for U.S. Appl. No. 13/562,129, filed Jul. 30, 2012, 7 pages. |
Notice of Allowance dated May 28, 2009, for U.S. Appl. No. 29/300,933, filed May 30, 2008, 7 pages. |
Otto, E. et al. (2000). “An Intelligent Diabetes Software Prototype: Predicting Blood Glucose Levels and Recommending Regimen Changes,” Diabetes Technology and Therapeutics 2(4):569-576. |
Pfohl, M. et al. (2000). “Spot Glucose Measurement in Epidermal Interstitial Fluid—An Alternative to Capillary Blood Glucose Estimation,” Experimental and Clinical Endocrinology & Diabetes 108(1):1-4. |
Princen, H.M. (May 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, I. Capillary Rise Between Two Cylinders,” Journal of Colloid and Interface Science 30(1):69-75. |
Princen, H.M. (Jul. 1969). “Capillary Phenomena in Assemblies of Parallel Cylinders, II. Capillary Rise in Systems with More Than Two Cylinders,” Journal of Colloid and Interface Science 30(3):359-371. |
Rebrin, K. et al. (Sep. 1999). “Subcutaneous Glucose Predicts Plasma Glucose Independent of Insulin: Implications for Continuous Monitoring,” American Journal of Physiology 277(3):E561-E571. |
Rosen, S. (1999). “Road to New-Age Glucose Monitoring Still Rocky,” Diagnostic Insight, pp. 4-5, 12-13, 16. |
Smart, W.H. et al. (2000). “The Use of Silicon Microfabrication Technology in Painless Glucose Monitoring, ”Diabetes Technology & Therapeutics 2(4):549-559. |
Spielman, A. et al. (2001). Mosquito: A Natural History of Our Most Persistent and Deadly Foe, First Edition, Hyperion, New York, NY, 3 pages. (Table of Contents Only). |
Sonntag, O. (1993). Ektachem. Dry Chemistry, Analysis With Carrier-Bound Reagents, Elsevier Science Publishers, 57 pages. |
Straub F.B. (Mar. 1939). “Isolation and Properties of a flavoprotien from Heart Muscle Tissue”, Biochemical Journal 33: 787-792. |
Svedman, C. et al. (Apr. 1999). “Skin Mini-Erosion Technique for Monitoring Metabolites in Interstitial Fluid: Its Feasibility Demonstrated by OGTT Results in Diabetic and Non-Diabetic Subjects,” Scand. J. Clin. Lab. Invest. 59(2):115-123. |
Tietz, N. W. (1986). Textbook of Clinical Chemistry, W.B. Saunders Company, pp. 1533 and 1556. |
Trinder, P. (1969). “Determination of Glucose in Blood Using Glucose Oxidase with an Alternate Oxygen Acceptor,” Annals of Clinical Biochemistry 6:24-28. |
U.S. Precision Lens, Inc. (1983).The Handbook of Plastic Optics. |
Wikipedia (2016). “Capillary action,” 7 pages. |
Written Opinion dated May 2, 2007, for PCT Application No. PCT/US2006/37923, filed on Sep. 9, 2006, 5 pages. |
Written Opinion dated Aug. 16, 2007 for PCT Application No. PCT/US2006/038163, filed on Sep. 29, 2006, 4 pages. |
Written Opinion dated Dec. 3, 2004, for PCT Application No. PCT/US2004/08798, filed on Mar. 24, 2004, 4 pages. |
Written Opinion dated Aug. 17, 2007 for PCT/US2006/38049, filed on Sep. 29, 2006, 6 pages. |
Written Opinion dated Oct. 19, 2012 for PCT Application No. PCT/US2012/049629, filed on Aug. 3, 2012, 7 pages. |
Written Opinion of the International Searching Authority dated Jan. 16, 2008, for PCT Application No. PCT/US2006/022840, filed on Jun. 13, 2006, 3 pages. |
Written Opinion dated Aug. 20, 2007 for PCT Application No. PCT/US2006/37245, filed on Sep. 26, 2006, 7 pages. |
Yum, S. I. et al. (Nov. 1, 1999). “Capillary Blood Sampling for Self-Monitoring of Blood Glucose,” Diabetes Technology & Therapeutics, 1(1):29-37. |
Non-Final Office Action dated Mar. 21, 2017, for U.S. Appl. No. 15/177,041, filed Jun. 8, 2016, 11 pages. |
Extended European search report dated Apr. 12, 2017, from the European Patent Office for Application No. 16200931.0, filed Sep. 26, 2006, 9 pages. |
Office Action dated May 15, 2017, for U.S. Appl. No. 14/743,867, filed Jun. 18, 2015, 7 pages. |
Extended European Search Report dated Nov. 8, 2016 from the European Patent Office for Application No. 16167087.2, filed Aug. 3, 2012, 6 pages. |
Non-Final Office Action dated Dec. 16, 2016, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 11 pages. |
Non-Final Office Action dated May 15, 2017, by the United States Patent and Trademark Office for U.S. Appl. No. 14/743,867, filed Jun. 18, 2015. |
Notice of Allowance dated Aug. 18, 2017, for U.S. Appl. No. 13/566,886, filed Aug. 3, 2012, 10 pages. |
Notice of Allowance dated Aug. 4, 2017, by the United States Patent and Trademark Office for U.S. Appl. No. 14/743,867, filed Jun. 18, 2015, 7 pages. |
Final Office Action dated Nov. 29, 2017, for U.S. Appl. No. 15/177,041, filed Jun. 8, 2016, 13 pages. |
Final Office Action dated Mar. 21, 2018, for U.S. Appl. No. 14/321,631, filed Jul. 1, 2014, 18 pages. |
Non-Final Office Action dated Nov. 6, 2018, for U.S. Appl. No. 14/321,631, filed Jul. 1, 2014, 18 pages. |
Number | Date | Country | |
---|---|---|---|
20160367178 A1 | Dec 2016 | US |
Number | Date | Country | |
---|---|---|---|
60721966 | Sep 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11529614 | Sep 2006 | US |
Child | 15191434 | US |